Severity of Chest Imaging is Correlated with Risk of Acute Neuroimaging Findings among Patients with COVID-19

References

1. 1.↵
   Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). January 7, 2021. https://coronavirus.jhu.edu/map.html. Accessed November 4, 2020
2. 2.↵
   2. Bhayana R,
   3. Som A,
   4. Li MD, et al

   . Abdominal imaging findings in COVID-19: preliminary observations. Radiology 2020;297:E207–15 doi:10.1148/radiol.2020201908 pmid:32391742

   CrossRefPubMed
3. 3.↵
   2. Puelles VG,
   3. Lütgehetmann M,
   4. Lindenmeyer MT, et al

   . Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020;383:590–92 doi:10.1056/NEJMc2011400 pmid:32402155

   CrossRefPubMed
4. 4.↵
   2. Zaim S,
   3. Chong JH,
   4. Sankaranarayanan V, et al

   . COVID-19 and multiorgan response. Curr Probl Cardiol 2020;45:100618 doi:10.1016/j.cpcardiol.2020.100618 pmid:32439197

   CrossRefPubMed
5. 5.↵
   2. Wang D,
   3. Hu B,
   4. Hu C, et al

   . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–69 doi:10.1001/jama.2020.1585 pmid:32031570

   CrossRefPubMed
6. 6.↵
   2. Li MY,
   3. Li L,
   4. Zhang Y, et al

   . Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020;9:45 doi:10.1186/s40249-020-00662-x pmid:32345362

   CrossRefPubMed
7. 7.↵
   2. De Felice FG,
   3. Tovar-Moll F,
   4. Moll J, et al

   . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci 2020;43:355–57 doi:10.1016/j.tins.2020.04.004 pmid:32359765

   CrossRefPubMed
8. 8.↵
   2. Poyiadji N,
   3. Shahin G,
   4. Noujaim D, et al

   . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology 2020;296:E119–20 doi:10.1148/radiol.2020201187 pmid:32228363

   CrossRefPubMed
9. 9.↵
   2. Ye M,
   3. Ren Y,
   4. Lv T

   . Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 2020;88:945–46 doi:10.1016/j.bbi.2020.04.017 pmid:32283294

   CrossRefPubMed
10. 10.↵
    2. Moriguchi T,
    3. Harii N,
    4. Goto J, et al

    . A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis 2020;94:55–58 doi:10.1016/j.ijid.2020.03.062 pmid:32251791

    CrossRefPubMed
11. 11.↵
    2. Lang M,
    3. Li MD,
    4. Buch K, et al

    . Risk of acute cerebrovascular events in patients with COVID-19 infection. AJNR Am J Neuroradiol 2020;41:E92–93 doi:10.3174/ajnr.A6796 pmid:32855192

    FREE Full Text
12. 12.↵
    2. Josephson SA,
    3. Kamel H

    . Neurology and COVID-19. JAMA 2020;324:1139–40 doi:10.1001/jama.2020.14254 pmid:32960246

    CrossRefPubMed
13. 13.↵
    2. Mao L,
    3. Jin H,
    4. Wang M, et al

    . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

    CrossRefPubMed
14. 14.↵
    2. Jain R,
    3. Young M,
    4. Dogra S, et al

    . COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci 2020;414:116923 doi:10.1016/j.jns.2020.116923 pmid:32447193

    CrossRefPubMed
15. 15.↵
    2. Feng Z,
    3. Yu Q,
    4. Yao S, et al

    . Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics. Nat Commun 2020;11:4968 doi:10.1038/s41467-020-18786-x pmid:33009413

    CrossRefPubMed
16. 16.↵
    2. Li MD,
    3. Arun NT,
    4. Gidwani M, et al

    . Automated assessment and tracking of COVID-19 pulmonary disease severity on chest radiographs using convolutional Siamese neural networks. Radiology: Artificial Intelligence 2020 Jul 22. [Epub ahead of print] doi:10.1148/ryai.2020200079

    CrossRef
17. 17.↵
    2. Toussie D,
    3. Voutsinas N,
    4. Finkelstein M, et al

    . Clinical and chest-radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology 2020;297:E197–206 doi:10.1148/radiol.2020201754 pmid:32407255

    CrossRefPubMed
18. 18.↵
    2. Li MD,
    3. Arun NT,
    4. Aggarwal M, et al

    . Improvement and multi-population generalizability of a deep learning-based chest radiograph severity score for COVID-19. medRxiv 2020. doi:10.1101/2020.09.15.20195453. Accessed November 5, 2020

    CrossRef
19. 19.↵
    2. Steinberger S,
    3. Lin B,
    4. Bernheim A, et al

    . CT features of coronavirus disease (COVID-19) in 30 pediatric patients. AJR Am J Roentgenol 2020;215:1303–11 doi:10.2214/AJR.20.23145 pmid:32442030

    CrossRefPubMed
20. 20.↵
    2. Robin X,
    3. Turck N,
    4. Hainard A, et al

    . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77 doi:10.1186/1471-2105-12-77 pmid:21414208

    CrossRefPubMed
21. 21.↵
    2. Simpson S,
    3. Kay FU,
    4. Abbara S, et al

    . Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and Radiological Society of North America—secondary publication. J Thorac Imaging 2020;35:219–27 doi:10.1097/RTI.0000000000000524 pmid:32324653

    CrossRefPubMed
22. 22.↵
    2. Lang M,
    3. Buch K,
    4. Li MD, et al

    . Leukoencephalopathy associated with severe COVID-19 infection: sequela of hypoxemia? AJNR Am J Neuroradiol 2020;41:1641–45 doi:10.3174/ajnr.A6671 pmid:32586959

    Abstract/FREE Full Text
23. 23.↵
    2. Yoon BC,
    3. Buch K,
    4. Lang M, et al

    . Clinical and neuroimaging correlation in patients with COVID-19. AJNR Am J Neuroradiol 2020;41:1791–96 doi:10.3174/ajnr.A6717 pmid:32912875

    Abstract/FREE Full Text
24. 24.↵
    2. Huang C,
    3. Wang Y,
    4. Li X, et al

    . Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet 2020;395:497–506 doi:10.1016/S0140-6736(20)30183-5 pmid:31986264

    CrossRefPubMed
25. 25.↵
    2. Pan Y,
    3. Guan H,
    4. Zhou S, et al

    . Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol 2020;30:3306–09 doi:10.1007/s00330-020-06731-x pmid:32055945

    CrossRefPubMed
26. 26.↵
    2. Shi H,
    3. Han X,
    4. Jiang N, et al

    . Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20:425–34 doi:10.1016/S1473-3099(20)30086-4 pmid:32105637

    CrossRefPubMed
27. 27.↵
    2. Chung M,
    3. Bernheim A,
    4. Mei X, et al

    . CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020;295:202–07 doi:10.1148/radiol.2020200230 pmid:32017661

    CrossRefPubMed
28. 28.↵
    2. Lang M,
    3. Som A,
    4. Mendoza DP, et al

    . Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 2020;20:1365–66 doi:10.1016/S1473-3099(20)30367-4 pmid:32359410

    CrossRefPubMed
29. 29.↵
    2. Lang M,
    3. Som A,
    4. Carey D, et al

    . Pulmonary vascular manifestations of COVID-19 pneumonia. Radiology: Cardiothoracic Imaging 2020;2:e200277 doi:10.1148/ryct.2020200277

    CrossRef
30. 30.↵
    2. Scholkmann F,
    3. Nicholls J

    . Pulmonary vascular pathology in COVID-19. N Engl J Med 2020;383:887–88 doi:10.1056/NEJMc2022068 pmid:32678533

    CrossRefPubMed
31. 31.↵
    2. Ackermann M,
    3. Verleden SE,
    4. Kuehnel M, et al

    . Pulmonary vascular endotheliitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020;383:120–28 doi:10.1056/NEJMoa2015432 pmid:32437596

    CrossRefPubMed
32. 32.↵
    2. Chan NC,
    3. Weitz JI

    . COVID-19 coagulopathy, thrombosis, and bleeding. Blood 2020;136:381–83 doi:10.1182/blood.2020007335 pmid:32702124

    CrossRefPubMed
33. 33.↵
    2. Becker RC

    . COVID-19 update: COVID-19-associated coagulopathy. J Thromb Thrombolysis 2020;50:54–67 doi:10.1007/s11239-020-02134-3 pmid:32415579

    CrossRefPubMed
34. 34.↵
    2. McElvaney OJ,
    3. McEvoy NL,
    4. McElvaney OF, et al

    . Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 2020;202:812–21 doi:10.1164/rccm.202005-1583OC pmid:32584597

    CrossRefPubMed
35. 35.↵
    2. Mehraeen E,
    3. Behnezhad F,
    4. Amin Salehi M, et al

    . Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol 2020 Jun 17. [Epub ahead of print] doi:10.1007/s00405-020-06120-6 pmid:32556781

    CrossRefPubMed
36. 36.↵
    2. Conde Cardona G,
    3. Quintana Pajaro LD,
    4. Quintero Marzola ID, et al

    . Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci 2020;412:116824 doi:10.1016/j.jns.2020.116824 pmid:32299010

    CrossRefPubMed
37. 37.↵
    2. Delorme C,
    3. Paccoud O,
    4. Kas A, et al

    ; CoCo-Neurosciences study group and COVID SMIT PSL study group. Covid-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol 2020;27:2651–57 doi:10.1111/ene.14478 pmid:32881133

    CrossRefPubMed
38. 38.↵
    2. Fontana IC,
    3. Bongarzone S,
    4. Gee A, et al

    . PET imaging as a tool for assessing COVID-19 brain changes. Trends Neurosci 2020;43:935–38 doi:10.1016/j.tins.2020.10.010 pmid:33131922

    CrossRefPubMed
39. 39.↵
    2. Wenting A,
    3. Gruters A,
    4. van Os Y, et al

    . COVID-19 neurological manifestations and underlying mechanisms: a scoping review. Front Psychiatry 2020;11:860 doi:10.3389/fpsyt.2020.00860 pmid:32973590

    CrossRefPubMed
40. 40.↵
    2. Kreye J,
    3. Reincke SM,
    4. Pruss H

    . Do cross-reactive antibodies cause neuropathology in COVID-19? Nat Rev Immunol 2020;20:645–46 doi:10.1038/s41577-020-00458-y pmid:33024283

    CrossRefPubMed